Abstract
This systematic review aimed to explore the efficacy of both pharmacological and non-pharmacological interventions in managing hypertension during pregnancy. It analyzed high-quality randomized controlled trials (RCTs), focusing on outcomes related to maternal and fetal health. The findings demonstrated that antihypertensive medications, particularly labetalol and nifedipine, effectively reduced the risks of severe preeclampsia (PE), preterm birth, and other complications. Remote monitoring of blood pressure (BP) showed promise in improving postpartum care and addressing health disparities. While dietary interventions such as the Dietary Approaches to Stop Hypertension (DASH) diet offered metabolic benefits, their impact on preventing PE was inconclusive. The review highlights the need for a comprehensive approach to hypertension management, integrating medication, lifestyle interventions, and innovative monitoring strategies. It also emphasizes the importance of further research to refine non-pharmacological interventions and assess their long-term effectiveness. We believe these insights will help guide clinical practice, enhance maternal and fetal outcomes, and inform future research directions.